Mindshare Medical

Mindshare Medical was a private healthcare software company focused on evidence-based clinical decision support using radiomics, image pattern recognition, and deep learning applied to medical imaging. Its core product, RevealAI-Lung, was designed to assess the malignancy risk of pulmonary nodules on chest CT scans and support more effective lung cancer workup and follow-up decisions. The company combined imaging analytics with patient clinical data to provide personalized diagnostic guidance for providers, health systems, and risk-bearing organizations. In March 2021, substantially all of Mindshare Medical's assets were acquired by Precision Medical Ventures, and the business was subsequently rebranded as RevealDx. As a result, Mindshare Medical no longer appears to operate as an independent active company, although its technology continues under the RevealDx name.